<DOC>
	<DOCNO>NCT02018796</DOCNO>
	<brief_summary>The study conduct 4 site examine simplify outpatient medical abortion procedure use mifepristone misoprostol , option take mifepristone place woman 's choosing , work Kazakhstan . The investigator intend demonstrate efficacy oral administration 200 mg mifepristone sublingual administration 600 µg misoprostol gestation 70 day , well acceptability method . Research question include : 1 . What efficacy regimen 200 mg mifepristone , follow 24 48 hour later 600 µg sublingual misoprostol use gestation 70 day ? 2 . Is medical abortion procedure consist two visit acceptable woman Kazakhstan ? 3 . Are side effect associate sublingual use misoprostol acceptable woman ? 4 . When give choice , woman prefer take mifepristone clinic place choosing ?</brief_summary>
	<brief_title>Mifepristone Misoprostol Termination Pregnancy 70 Days ' Gestation Kazakhstan</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Have intrauterine pregnancy consistent gestational age le 71 day ; Be able understand willing sign consent form ; Be eligible medical abortion accord clinician 's assessment ; Be able return clinic able contact study staff emergency medical service , need ; Be willing provide address and/or telephone number purpose followup ; Agree comply study procedure visit schedule . Confirmed suspect ectopic pregnancy undiagnosed adnexal mass ; Chronic renal failure ; Concurrent longterm corticosteroid therapy ; History allergy mifepristone , misoprostol another prostaglandin ; History hemorrhagic disorder concurrent anticoagulant therapy ; History inherit porphyria ; Intrauterine device place ( must remove mifepristone administer ) .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>